Genetic engineering is used to produce human insulin. Restriction enzymes cut DNA at specific sites, and ligase enzymes join DNA pieces. The human insulin gene is isolated and inserted into a bacterial plasmid or virus vector. Bacteria are then genetically modified with this recombinant DNA. The modified bacteria can be grown in large quantities and produce human insulin, which can be extracted at large scale for treatment of diabetes.
Genetic engineering is used to produce human insulin. Restriction enzymes cut DNA at specific sites, and ligase enzymes join DNA pieces. The human insulin gene is isolated and inserted into a bacterial plasmid or virus vector. Bacteria are then genetically modified with this recombinant DNA. The modified bacteria can be grown in large quantities and produce human insulin, which can be extracted at large scale for treatment of diabetes.
Genetic engineering is used to produce human insulin. Restriction enzymes cut DNA at specific sites, and ligase enzymes join DNA pieces. The human insulin gene is isolated and inserted into a bacterial plasmid or virus vector. Bacteria are then genetically modified with this recombinant DNA. The modified bacteria can be grown in large quantities and produce human insulin, which can be extracted at large scale for treatment of diabetes.
Specification Point 5.12 Understand how restriction enzymes are used to cut DNA at specific sites and ligase enzymes are used to join pieces of DNA together
Genetic engineering is changing the
traits of one organism by inserting genetic material from another organism The organism receiving the genetic material is said to be ‘genetically modified’ Restriction enzymes cut DNA strands The DNA of the organism that now unequally to form ‘sticky ends’ contains DNA from another organism as well is known as ‘recombinant DNA’ The vector and the isolated gene are joined together by ligase enzyme The process is as follows: If two pieces of DNA have matching sticky ends (because they have been cut by the same restriction enzyme), The gene that is to be inserted is ligase will link them to form a single, located in the original organism (for unbroken molecule of DNA example, this could be the gene for human insulin) Restriction enzymes are used to isolate the required gene, leaving it with ‘sticky ends’ (a short section of unpaired bases) A vector, which is usually a bacterial plasmid or a virus, is cut by the same restriction enzyme leaving it with corresponding sticky ends DNA ligase is used to join two separate pieces from genetically modified bacteria that of DNA together are grown in a fermenter Insulin is needed in large quantities to help treat diabetes Vectors for Recombinant DNA Prior to the development of genetic Specification Point 5.13 engineering, insulin for human use was Understand how plasmids and viruses collected from pigs can act as vectors, which take up pieces Bacteria are now genetically of DNA, and then insert this engineered to produce human recombinant DNA into other cells insulin which can be collected and A vector is a vehicle to artificially purified for use with no fear of rejection carry foreign genetic material into another cell, where it can be replicated and/or expressed The two main types of vectors are bacterial plasmids and viruses
Vectors can be bacterial plasmids or viruses
Plasmids are circles of DNA that are found in bacteria The process of creating human insulin by When the bacteria reproduce genetic engineering the plasmids are copied as well and so Once some bacteria have been a recombinant plasmid can quickly be genetically engineered they are grown in spread as the bacteria multiply and they will then all express the gene large quantities in a fermenter Each bacterial cell will produce a tiny Viruses will carry recombinant DNA and infect organisms that they come mass of insulin into contact with, making the host In this way large quantities of insulin organism express the recombinant protein can be produced, extracted and DNA purified for use by diabetics Manufacture of Insulin Specification Point 5.14 Understand how large amounts of human insulin can be manufactured